"She said the device could be used in a doctor's clinic, lab or hospital-to test antibiotic sensitivity of pathogens found in human biological fluids and tissue scrapings. The novel device which comes with a ready-to-use kit could provide results in a couple of hours as against the normal wait of 2-3 days for a sample to be cultured and tested in any lab."
Hyderabad, July 1 - BITS Pilani-Hyderabad has developed a new low-cost, ultra-rapid portable device to test antibiotic sensitivity of human urinary pathogens which can help curb antibiotic resistance to a large extent.

The institute Tuesday announced that it is transferring the technology to an incubate company Xcellence in Bio Innovation and Technologies Pvt Ltd (xBITS) for commercial scale production.

An agreement has been signed by V.S Rao, director, BITS Pilani with the representative from of xBITS in the presence of Suman Kapur who is the inventor of this technology, said a statement from BITS Pilani.

Rao said with this initiative of transferring the technology, BITS opened a new chapter in knowledge economy and enabled the spirit of entrepreneurship among BITS students and faculty.

Kapur described the technology as the fastest antibiotic finder available till date. This technology, developed with the funding received from NPMASS-DRDO is expected to obliterate the empirical use of antibiotics and thus help in fighting the growing microbial resistance to antibiotics.

She said the device could be used in a doctor's clinic, lab or hospital-to test antibiotic sensitivity of pathogens found in human biological fluids and tissue scrapings. The novel device which comes with a ready-to-use kit could provide results in a couple of hours as against the normal wait of 2-3 days for a sample to be cultured and tested in any lab.

Anuradha Pal, from xBITS, added that this innovative technology will take the Antibiotic Sensitivity Test (AST) to all people and places in India and other resource constraint settings where facilities for this test are not available.


comments powered by Disqus
Read more on:
 

PERMALINK

http://www.nerve.in/news:2535002385101
You can quote the permanent link above for a direct link to the story. We do not archive or expire our news stories.


STORY OPTIONS
  Email this story to a friend
  XML feed for India


 
COPYRIGHTS INFORMATION
All rights reserved for news content. Reproduction, storage or redistribution of Nerve content and articles in any medium is strictly prohibited.
Contact Nerve Staff for any feedback, corrections and omissions in news stories.
 

All rights reserved for the news content. Reproduction, storage or redistribution of Nerve content and articles in any medium is strictly prohibited.